BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31662449)

  • 1. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
    Xiao D; Dong Z; Zhen L; Xia G; Huang X; Wang T; Guo H; Yang B; Xu C; Wu W; Zhao X; Xu H
    Mol Cancer Res; 2020 Feb; 18(2):300-310. PubMed ID: 31662449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
    Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M
    Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
    Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
    Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
    Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
    Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Moutinho-Ribeiro P; Adem B; Batista I; Silva M; Silva S; Ruivo CF; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Lopes S; Vilas-Boas F; Durães C; Lopes J; Barroca H; Carneiro F; Melo SA; Macedo G
    Dig Liver Dis; 2022 Jul; 54(7):871-877. PubMed ID: 34840127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities.
    Moutinho-Ribeiro P; Batista IA; Quintas ST; Adem B; Silva M; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Medas R; Lopes S; Vilas-Boas F; Baptista M; Dias-Silva D; Esteves AL; Martins F; Lopes J; Barroca H; Carneiro F; Macedo G; Melo SA
    World J Gastroenterol; 2022 Aug; 28(31):4310-4327. PubMed ID: 36159010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
    Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
    World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer.
    Kitagawa T; Taniuchi K; Tsuboi M; Sakaguchi M; Kohsaki T; Okabayashi T; Saibara T
    Mol Oncol; 2019 Feb; 13(2):212-227. PubMed ID: 30358104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Peng Z; Tang Y; Liu W; Zhu B; Wang L; Ren C
    J Cell Mol Med; 2017 May; 21(5):838-847. PubMed ID: 28233416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer.
    Wang X; Zhong W; Bu J; Li Y; Li R; Nie R; Xiao C; Ma K; Huang X; Li Y
    Mol Carcinog; 2019 May; 58(5):674-685. PubMed ID: 30604894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons.
    Goh SK; Gold G; Christophi C; Muralidharan V
    ANZ J Surg; 2017 Dec; 87(12):987-992. PubMed ID: 28803454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
    Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X
    Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS In Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation.
    Yan S; Zheng H; Zhao J; Gao M; Zhang X
    Anal Chem; 2023 Jul; 95(27):10196-10203. PubMed ID: 37368911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer.
    Yu Y; Tong Y; Zhong A; Wang Y; Lu R; Guo L
    Medicine (Baltimore); 2020 Dec; 99(52):e23863. PubMed ID: 33350781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
    Murakami M; Nagai Y; Tenjin A; Tanaka Y
    Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.
    Luo G; Fan Z; Cheng H; Jin K; Guo M; Lu Y; Yang C; Fan K; Huang Q; Long J; Liu L; Xu J; Lu R; Ni Q; Warshaw AL; Liu C; Yu X
    Pancreatology; 2018 Dec; 18(8):971-976. PubMed ID: 30131287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.